Why Nobody Wants ICH Q14 — And Why That’s Exactly the Problem

3 min. reading time | by Dr. Anamarija Ćurić, nuvalore GmbH  
Published in LOGFILE 13/2026 

The ICH Guideline Q14 “Analytical Procedure Development” was published in November 2023. This forward-looking and regulatory-savvy document builds upon the content of ICH Q2(R2) “Validation of Analytical Procedures” and incorporates elements from ICH Q8 “Pharmaceutical Development” and ICH Q9(R1) “Quality Risk Management.” Although this guideline holds great potential, it has received little attention in practice so far. Dr. Anamarija Curic explains the reasons behind this.

The big silence after publication

When the ICH Guideline Q14 came into force in the summer of 2024, the tone was clear: a paradigm shift, analytical Quality by Design, a lifecycle approach to methodologies, and scientific freedom. It sounded like a new beginning. Two years on, there is a striking silence. In the laboratories, business continues as usual.

Future-oriented, but non-binding 

ICH Q14 is perhaps the most elegant regulatory document of recent years, and at the same time one of the least prescriptive. The basic idea of distinguishing between a minimal and an enhanced development approach is a sound regulatory one. It takes into account product complexity, company size and risk profile. Yet this is precisely where its weakness lies. 

That's because in everyday GMP practice, a simple logic applies: if it doesn't result in a finding, it isn't a priority. ICH Q2(R2) is sufficient to ensure audit readiness. ICH Q14 does not offer any immediate compliance benefits, but ‘merely’ a long-term perspective. The key added value of ICH Q14 lies not in the present, but in the future: more robust methods, easier changes, less post-approval pain, and greater flexibility throughout the lifecycle. The benefits often only become apparent years later. 

Q14 is not suitable for established organisations

The guideline calls for integrated collaboration between development, quality control (QC), quality assurance (QA) and regulatory affairs. It requires statistical expertise that goes beyond linear models. It requires that methodological knowledge be nurtured like a product, rather than filed away like a test report.

In many companies, however, the reality is fragmented. Quality control is overburdened with operational tasks, development is out of sync with the rest of the organisation, and knowledge is lost whenever staff change. Within this system, ICH Q14 does not appear to be a help, but rather a source of discord. QC must be understood as a strategic function. QC should not treat analytical methods merely as testing tools, but as vehicles for process and product knowledge.

Q14 is too academic and out of touch with practice 

The strongest criticism levelled at ICH Q14 is that it contains too much theory, too much statistics and too little practical value. 

This criticism should be taken seriously. There is indeed a risk that Q14 will become stuck in PowerPoint design spaces and ATP texts without improving day-to-day laboratory practice. If poorly implemented, it becomes a paper exercise.

Yet this criticism misses the point. It is not Q14 that is academic, but rather that its implementation is often poorly executed. The guideline does not force over-engineering. On the contrary: it explicitly allows for minimal approaches. The problem is not the guideline. The problem is that it is either ignored or over-engineered, rather than being applied judiciously.

Q14 is not a tool. It is a mirror. 

So why does nobody want ICH Q14? 

Because it doesn’t deliver a quick win but requires a fundamental re-evaluation. And because it shows that analytical GMP is at a fork in the road. ICH Q14 is not a project that can simply be ‘introduced’.

It is a conceptual framework that helps organisations move forward.

Those who ignore it today may be acting efficiently in the short term. Those who need it tomorrow will wonder why they didn’t start yesterday.

The question is, when will ICH Q14 be needed? The question is, when will the cost of not using it exceed the effort required to implement it? And this calculation will be made sooner than many expect.

Do you have any questions or suggestions? Please contact us at: redaktion@gmp-verlag.de